ExCellThera’s stem cell expansion approach may benefit AML patients undergoing transplants

Patients suffering from acute myeloid leukemia (AML), who require stem cell transplantation as part of their treatment, may now benefit from a new best-in-class process that improves the viability and success of cord blood stem cell transplantation.

[Read the full article here]

Comments are closed.